Skip to content

Abstract 8473: Vascular Dysfunction, Body Composition and Cardiovascular Outcomes in Patients with Diabetes

Nov 2026 · Circulation · 0 citations

Abstract

Background: Diabetes confers increased yet heterogeneous cardiovascular risk. Coronary microvascular dysfunction (CMD) is a robust, independent predictor of adverse outcomes and a key link between metabolic dysregulation and cardiovascular events. Excess visceral and ectopic adiposity, which are features of diabetes, may contribute to CMD beyond traditional risk factors, with adipose tissue quality capturing risk not reflected by body mass index (BMI). However, the interplay between CT-derived body composition, CMD, and cardiovascular risk in diabetes remains poorly defined. Methods: In this single-center retrospective cohort study, patients with diabetes undergoing pharmacologic stress PET were stratified by the presence of CMD (myocardial flow reserve [MFR] <2), excluding those with known obstructive epicardial coronary artery disease (prior revascularization or abnormal perfusion), heart transplantation, or missing data. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of all-cause death, myocardial infarction, or heart failure admission. Multivariable logistic regression was used to identify independent CMD predictors, with discrimination assessed using receiver operating characteristic (ROC) analysis. Cox proportional hazards models were used to assess associations with MACE. Model performance was assessed using likelihood ratio χ 2 (LR χ 2 ), Akaike information criterion (AIC), and concordance index (C-index). Results: Among 518 patients with diabetes (age 63 ± 11.3 years, 43% male, HbA1c 7.5 ± 1.9 %), CMD was present in 32%. Patients with CMD were older, had lower BMI, and a higher prevalence of hypertension and peripheral vascular disease. On multivariable analysis, age, hypertension, peripheral vascular disease, hemoglobin, and non-epicardial visceral adipose tissue (non-EAT VAT) density independently predicted CMD with corresponding ORs of 1.03, 2.69, 3.17, 0.59, and 1.40, respectively (AUC 0.79; 95% CI 0.75-0.83) (Figures 1 and 2) . Over a median follow-up of 3.1 years (IQR 1.5 -8.3), 185 MACE events occurred. Beyond traditional clinical risk factors, hemoglobin, and MFR—but not non-EAT VAT density—independently predicted MACE (adjusted HR 0.84 [0.76-0.93], p <0.001; 0.73 [0.58-0.91], p <0.01; 1.03 [1-1.05], p 0.07). The final model included traditional risk factors and hemoglobin (Model A), with the sequential addition of MFR (Model B) and non-EAT VAT density (Model C). Model fit improved progressively (LR χ 2 : 57.41→66.98→70.32; AIC: 1760.9→1753.3→1751.9), with modest discrimination gains (C-index: 0.677→0.688→0.693) (Table 1). Conclusion: Visceral adipose tissue density was independently linked to CMD in patients with diabetes, supporting a role for adipose remodeling in coronary microvascular dysfunction, but without incremental MACE risk stratification.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.